Information Letter on VOTRIENT® (pazopanib)
2013.07.30
Active substance: pazopanib
Important change to frequency of serum liver test monitoring for hepatotoxicity.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN
BfArM - Federal Institute for Drugs and Medical Devices
Navigation and service
